{'Year': '2011', 'Month': 'Oct'}
Pharmacogenetics of genes across the doxorubicin pathway.
A large number of genetic polymorphisms have been reported in the genes that mediate the metabolism, transport and pharmacological activity of doxorubicin. The clinical significance of these is still undergoing evaluation.